Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1867 studies found for:    Hyperinsulinism
Show Display Options
Rank Status Study
1 Recruiting A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Cohort 1;   Drug: Cohort 2;   Drug: Cohort 3;   Drug: Cohort 4
2 Recruiting Fluorodopa F 18 in Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Fluorodopa F 18
3 Completed Sandostatine® LP and Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Sandostatine LP
4 Recruiting Sirolimus for the Treatment of Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: Sirolimus
5 Completed
Has Results
Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Other: Vehicle
6 Unknown  Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
Condition: Congenital Hyperinsulinism
Intervention: Drug: Lanreotide autogel
7 Completed Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism
Condition: Non-focal Congenital Hyperinsulinism
Intervention: Procedure: restrictive pancreatic resection
8 Recruiting CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Glucagon;   Other: Placebo
9 Completed Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: recombinant human insulin-like growth factor I
10 Completed Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: insulin-like growth factor I
11 Completed Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: insulin-like growth factor I
12 Recruiting Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Drug: placebo
13 Recruiting Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39);   Other: placebo
14 Active, not recruiting Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Conditions: Congenital Hyperinsulinism;   Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy;   CHI;   PHHI
Interventions: Drug: F-DOPA;   Radiation: PET scan
15 Completed Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
Conditions: Hyperinsulinism;   Polycystic Ovary Syndrome
Interventions: Drug: clomiphene citrate;   Drug: metformin
16 Completed Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome;   Hyperinsulinism
Interventions: Drug: clomiphene citrate;   Drug: metformin
17 Available Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia
Condition: Congenital Hyperinsulinism
Intervention: Drug: Pasireotide
18 Completed Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men
Conditions: Obesity;   Hyperinsulinism
Intervention: Drug: Diazoxide
19 Unknown  Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism
Condition: Conservatively Treated CHI Patients
Intervention:
20 Completed Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
Conditions: Hyperinsulinism;   Hypoglycemia;   Insulinoma
Intervention: Other: 111In-exendin-4 imaging

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.